Oncaspar Related Clinical Trials
ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase [Recruiting]
SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma [Recruiting]
Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies [Recruiting]
A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and Lymphoma [Terminated]
Trial of Oncaspar� and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia [Recruiting]
EZN-2285 or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia [Recruiting]
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) [Recruiting]
Clofarabine or High-Dose Cytarabine, Pegaspargase, and Combination Chemotherapy Followed by Daunorubicin Hydrochloride or Doxorubicin Hydrochloride in Treating Young Patients With Acute Lymphoblastic Leukemia [Recruiting]
Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia [Recruiting]
Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma [Not yet recruiting]
Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Not yet recruiting]
Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL) [Recruiting]
Treatment of Acute Lymphoblastic Leukemia in Children [Recruiting]
Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS [Recruiting]
Intensified Post Remission Therapy Containing PEG-Asparaginase [Recruiting]
Treatment of Natural Killer/T Cell Lymphoma-I/II [Recruiting]
Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage [Recruiting]
A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic Leukaemia [Recruiting]
Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Not yet recruiting]
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia [Recruiting]
Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma [Recruiting]
Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma [Recruiting]
Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses [Recruiting]
A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL) [Recruiting]
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma [Recruiting]
Decitabine, Vorinostat, and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma That Has Relapsed or Not Responded to Treatment [Recruiting]
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [Recruiting]
Prediction and Prevention of PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With Acute Lymphoblastic Leukemia [Recruiting]
Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia [Recruiting]
A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL [Not yet recruiting]
ALL Adult Consortium Trial: Adult ALL Trial [Recruiting]
Treatment of Older Adults With Acute Lymphoblastic Leukemia [Recruiting]
A Study of Children With Refractory or Relapsed ALL [Completed]
Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Recruiting]
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Not yet recruiting]
ABT-751 With Chemotherapy for Relapsed Pediatric ALL [Recruiting]
Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia [Recruiting]
NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia [Recruiting]
Combination Chemotherapy in Treating Children With Lymphoma [Active, not recruiting]
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia [Completed]
Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma [Active, not recruiting]
Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia [Completed]
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia [Completed]
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia [Active, not recruiting]
Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia [Active, not recruiting]
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia [Completed]
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia [Completed]
Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia [Active, not recruiting]
Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia [Active, not recruiting]
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia [Completed]
Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia [Recruiting]
Epratuzumab and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia [Recruiting]
Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia [Recruiting]
Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Recruiting]
Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) [Recruiting]
Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia [Terminated]
Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia [Recruiting]
Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia [Active, not recruiting]
Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma [Recruiting]
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia [Active, not recruiting]
Erwinase Master Treatment Protocol [Available]
|
